Business

Pharma Stock Surges on Deal with Novo Nordisk

Updated 2026-09-25 10:10 UTC 1 source Positive

Nanexa, a Swedish microcap company, saw its stock price surge 150% after announcing a licensing deal with European pharma giant Novo Nordisk for injectables.

Coverage timeline — 1 article
CNBC
Shares in Swedish microcap stock Nanexa more than doubled after the drug-delivery group revealed a licensing deal with European pharma giant Novo Nordisk.
2026-09-25 09:58 UTC
Share: Twitter / X LinkedIn